CLINICAL_TRIALS
trial_result
· 2010-02-02
Clinical Trial Update: Filtered Trial for Telmisartan 40mg Non-responder [Phase 3]
Summary
Phase 3 trial update evaluating telmisartan 40 mg in hypertension non-responders. Results were posted February 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-02-02